| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |